Search research articles
Contact Us
Filters
Showing results (201-210 of 244) with videos related to
Page
of 25
Sort By:
Leukemia & Lymphoma
|
August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution
S Oddou, N Vey, P Viens, et al.
Oncogene
|
May 26, 2007
ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines
C Ginestier, J Adélaïde, A Gonçalvès, et al.
British Journal of Cancer
|
March 4, 2010
Participants' uptake of clinical trial results: a randomised experiment
J Mancini, D Genre, F Dalenc, et al.
Anticancer Research
|
April 27, 1999
Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy
M P Mathoulin-Portier, P Meynard, M C Charton-Bain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2011
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
R Sabatier, J C Eymard, J Walz, et al.
Anticancer Research
|
August 6, 2000
Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II study
D Genre, P Viens, G Gravis, et al.
Bone Marrow Transplantation
|
June 25, 2002
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens
D Genre, P Viens, F Bertucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients
J Alexandre, P Bleuzen, J Bonneterre, et al.
Leukemia & Lymphoma
|
January 1, 1996
High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's disease
J Fleury, M Legros, P Colombat, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
April 26, 2011
[Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival]
B Farnault, L Moureau-Zabotto, C de Chaisemartin, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 244) with videos related to
Sort By:
Page
of 25
Leukemia & Lymphoma
|
August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution
S Oddou, N Vey, P Viens, et al.
Oncogene
|
May 26, 2007
ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines
C Ginestier, J Adélaïde, A Gonçalvès, et al.
British Journal of Cancer
|
March 4, 2010
Participants' uptake of clinical trial results: a randomised experiment
J Mancini, D Genre, F Dalenc, et al.
Anticancer Research
|
April 27, 1999
Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy
M P Mathoulin-Portier, P Meynard, M C Charton-Bain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2011
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
R Sabatier, J C Eymard, J Walz, et al.
Anticancer Research
|
August 6, 2000
Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II study
D Genre, P Viens, G Gravis, et al.
Bone Marrow Transplantation
|
June 25, 2002
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens
D Genre, P Viens, F Bertucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients
J Alexandre, P Bleuzen, J Bonneterre, et al.
Leukemia & Lymphoma
|
January 1, 1996
High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's disease
J Fleury, M Legros, P Colombat, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
April 26, 2011
[Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival]
B Farnault, L Moureau-Zabotto, C de Chaisemartin, et al.
Page
of 25